Literature DB >> 12770677

Use of an anesthesia cerebral monitor bispectral index to assess burst-suppression in pentobarbital coma.

Pretti Jaggi1, Michael J Schwabe, Kelly Gill, Ira N Horowitz.   

Abstract

A seven-year-old child with generalized status epilepticus who was placed in a barbiturate coma was monitored with the bispectral index monitor in addition to the standard full channel electroencephalogram. This child had a low bispectral index number and high suppression ratio on the bispectral index monitor when the desired level of pentobarbital coma was induced. There was excellent correlation of the bispectral index monitor to the suppression ratio. The burst rate also correlated well to the bispectral index number and to the suppression ratio. Therefore the bispectral index monitor could allow the patient in barbiturate coma to leave the intensive care unit for diagnostic or therapeutic procedures and may one day replace the full-channel electroencephalogram in the management of patients in barbiturate coma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12770677     DOI: 10.1016/s0887-8994(02)00633-1

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  3 in total

1.  Comparative Study of Brain Protection Effect between Thiopental and Etomidate Using Bispectral Index during Temporary Arterial Occlusion.

Authors:  Tae Kwan Kim; Ik Seong Park
Journal:  J Korean Neurosurg Soc       Date:  2011-12-31

2.  Monitoring burst suppression in critically ill patients: Multi-centric evaluation of a novel method.

Authors:  Franz Fürbass; Johannes Herta; Johannes Koren; M Brandon Westover; Manfred M Hartmann; Andreas Gruber; Christoph Baumgartner; Tilmann Kluge
Journal:  Clin Neurophysiol       Date:  2016-02-09       Impact factor: 3.708

3.  Continuous noninvasive monitoring of barbiturate coma in critically ill children using the Bispectral index monitor.

Authors:  Sandra A Prins; Matthijs de Hoog; Joleen H Blok; Dick Tibboel; Gerhard H Visser
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.